Cancer Biopsies Market Report
First published: 07 October 2024 | Last updated: 25 May 2026 | Report Code: cancer-biopsies
Cancer Biopsies Market — USD 10 billion in 2023, Growing to USD 17.46B by 2033 at 5.6% CAGR
This report provides a comprehensive analysis of the Cancer Biopsies market, focusing on market size, growth potential, key regional insights, and future trends from 2023 to 2033. It aims to deliver valuable insights for stakeholders and industry players to make informed decisions.
Key Takeaways
- Global market rises from $10.00 Billion in 2023 to $17.46 Billion by 2033, reflecting a 5.6% CAGR over the forecast period.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Europe expands from $2.96 Billion in 2023 to $5.18 Billion in 2033, supported by diagnostic and clinical investments.
- Liquid, needle, and surgical biopsy segments coexist across clinical and research applications, with hospitals and diagnostic labs as primary end users.
Cancer Biopsies Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The Cancer Biopsies Market Report documents steady growth driven by heightened demand for early and accurate cancer diagnosis, technological progress in sampling methods, and increased investment in diagnostic infrastructure. The market value moves from $10.00 Billion in 2023 to $17.46 Billion in 2033 at a CAGR of 5.6% during 2023 to 2033. Regional dynamics show North America as the largest market, with Europe, Asia Pacific, Latin America, and the Middle East and Africa each contributing to overall expansion. Key trends include advancement in minimally invasive techniques, broader adoption of liquid biopsy approaches, and integration of digital tools in laboratory workflows. Leading companies such as Roche Diagnostics, Thermo Fisher Scientific, Becton, Dickinson and Company (BD), Illumina, Inc., and Siemens Healthineers are active in product development and commercialization. Market participants should focus on enhancing procedural efficiency, supporting clinical validation, and responding to regulatory and training requirements to capture growth opportunities across hospital, diagnostic laboratory, and academic research channels.
Key Growth Drivers
- Rising demand for early cancer detection increases need for diagnostic biopsy procedures and related services.
- Technological improvements in minimally invasive and liquid biopsy methods enhance clinical adoption and patient acceptance.
- Investment in diagnostic infrastructure and laboratory capabilities supports broader deployment across hospitals and specialist centers.
- Ongoing research activity and clinical trials expand use cases for biopsies in treatment monitoring and precision medicine.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $10.00 Billion |
| CAGR (2023-2033) | 5.6% |
| 2033 Market Size | $17.46 Billion |
| Top Companies | Roche Diagnostics, Thermo Fisher Scientific, Becton, Dickinson and Company (BD), Illumina, Inc., Siemens Healthineers |
| Published Date | 07 October 2024 |
| Last Modified Date | 25 May 2026 |
Cancer Biopsies Market Overview
Customize Cancer Biopsies Market Report market research report
- ✔ Get in-depth analysis of Cancer Biopsies market size, growth, and forecasts.
- ✔ Understand Cancer Biopsies's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Cancer Biopsies
What is the Market Size & CAGR of Cancer Biopsies Market Report market in 2023?
Cancer Biopsies Industry Analysis
Cancer Biopsies Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Cancer Biopsies Market Report Market Analysis Report by Region
Europe Cancer Biopsies Market Report:
Europe grows from $2.96 Billion in 2023 to $5.18 Billion in 2033. Regional expansion is linked to increased diagnostic capacity, clinical research activity, and greater use of biopsy approaches for precision medicine and treatment monitoring.Asia Pacific Cancer Biopsies Market Report:
Asia Pacific grows from $1.91 Billion in 2023 to $3.34 Billion in 2033. Growth drivers include expanding healthcare infrastructure, rising cancer awareness, and wider availability of minimally invasive procedures in major markets.North America Cancer Biopsies Market Report:
North America is largest regional market, rising from $3.24 Billion in 2023 to $5.65 Billion in 2033. This growth reflects investments in diagnostic tools, established clinical networks, and adoption of advanced sampling techniques across hospitals and specialty centers.South America Cancer Biopsies Market Report:
Latin America grows from $0.62 Billion in 2023 to $1.08 Billion in 2033. Market progress is supported by scaling diagnostic services, growing clinical diagnostics adoption, and investments in laboratory resources.Middle East & Africa Cancer Biopsies Market Report:
Middle East and Africa grows from $1.27 Billion in 2023 to $2.21 Billion in 2033. Expansion is driven by improving healthcare access, development of diagnostic facilities, and increasing focus on cancer detection and monitoring.Tell us your focus area and get a customized research report.
Research Methodology
Cancer Biopsies Market Analysis By Type
Needle Biopsies dominated the market in 2023 with a size of $6.54 billion and is projected to reach $11.42 billion in 2033, holding a 65.37% market share. Surgical Biopsies and Liquid Biopsies also play crucial roles, with their respective market sizes reaching $4.43 billion and $1.62 billion by 2033.
Cancer Biopsies Market Analysis By Application
In 2023, the market for Diagnostic Testing applications is expected to generate $6.54 billion, indicating a 65.37% share. As accuracy in cancer diagnosis becomes more critical, demand for Treatment Monitoring and Research and Development applications will also escalate substantially.
Cancer Biopsies Market Analysis By End User
Hospitals remain the leading end-user, with a market size of $6.54 billion in 2023 and expected growth to $11.42 billion by 2033 due to high patient footfall and advanced diagnostics. Diagnostic Laboratories and Academic Research Institutions contribute significantly, with market sizes of $2.53 billion and $0.93 billion respectively.
Cancer Biopsies Market Analysis By Technological Advances
Traditional Methods capture the majority share of the market at 83.73% in 2023, amounting to $8.37 billion, while Advanced Technologies represent a growing segment, projected to reach $2.84 billion driven by innovation and shifting industry standards.
Cancer Biopsies Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Cancer Biopsies Industry
Roche Diagnostics:
A leader in diagnostics, Roche specializes in innovative cancer diagnostic solutions, significantly contributing to the biopsy segment through advanced technologies.Thermo Fisher Scientific:
Well-known for its scientific instruments and medical diagnostic tests, Thermo Fisher plays a crucial role in biopsy technologies worldwide.Becton, Dickinson and Company (BD):
BD is a prominent player focusing on developing medical devices and diagnostics, significantly impacting the Cancer Biopsies market with its innovative products.Illumina, Inc.:
Illumina is at the forefront of genomic solutions, providing advanced liquid biopsy technologies to enhance cancer diagnosis and monitoring.Siemens Healthineers:
Siemens is renowned for its diagnostic imaging and laboratory diagnostics, contributing extensively to the evolution of biopsy procedures.We're grateful to work with incredible clients.
FAQs
What is the market size of the Cancer Biopsies Market Report?
The market size is $10.00 Billion in 2023, with a projection to $17.46 Billion by 2033, based on the provided forecast period.
How big is the market expected to grow by 2033?
The market is expected to reach $17.46 Billion in 2033, rising from $10.00 Billion in 2023 according to the stated projections.
What is CAGR for the forecast period?
The compounded annual growth rate for 2023 to 2033 is 5.6% as specified in the report data.
Is there a single fastest Growing region in the Cancer Biopsies Market Report market?
No single fastest-growing region is stated for the Cancer Biopsies Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies are listed as major players?
Top companies named include Roche Diagnostics, Thermo Fisher Scientific, Becton, Dickinson and Company (BD), Illumina, Inc., and Siemens Healthineers.
How are biopsy segments categorized?
Segments include needle biopsies, surgical biopsies, and liquid biopsies, serving diagnostic testing, treatment monitoring, and research applications.
What end users drive demand for biopsies?
Primary end users comprise hospitals, diagnostic laboratories, and academic research institutions, each supporting clinical and research workflows.
What research methods supported the report findings?
The methodology includes primary interviews with industry experts, secondary research from company reports and publications, and data triangulation with internal validation.